A statement released on Thursday, January 26, 2023 from Dr. Janet Woodcock, the principal deputy commissioner of the Food and Drug Administration (FDA), announced that the FDA will work with Congress in formulating regulatory oversight to balance risk and access for products in the cannabidiol (CBD) market.
Our sister publication, Nutritional Outlook, provided thorough coverage of the FDA press release from Thursday, January 26th.
Click here to see the full article on this important update: https://www.nutritionaloutlook.com/view/fda-concludes-that-cbd-needs-its-own-regulatory-pathway-separate-from-dietary-supplements-and-food
Best of the Week: May 30 – June 5, 2025
June 6th 2025Here, we bring you our top five recent articles covering unlicensed cannabis purchases in New Jersey, cannabis found in Haribo candy, regulating cannabis beverages in Kentucky, appeals court rejects argument against federal prohibition, and organic certification in the industry.